Table 1.
% Before 2008 (total=36) |
% Since 2008 (total=214) |
|
---|---|---|
MIA model | 41% | 54% |
Surgical model | 28% | 33% |
Collagenase-induced OA | N/A | 3% |
Other OA-relevant models (ageing, obesity) | 3% | 3% |
Inflammatory models* | 16% | 6% |
Large animals | 19% | 7% |
Two models side-by-side | 5% | 8% |
Includes neurobiology | 25% | 35% |
Assesses more than one behavior | 16% | 32% |
Pain assessed at more than one time point | 25% | 40% |
Assesses pain and joint damage in same animals | 33% | 43% |
DMOAD testing with pain as secondary outcome | 5% | 11% |
These include intra-articular administration of CFA or carrageenan in order to trigger joint damage and pain. MIA = mono-iodoacetate; DMOAD = disease-modifying osteoarthritis drug.